181 related articles for article (PubMed ID: 21119195)
61. [Pulmonary arterial hypertension following pulmonary thromboembolism].
Wilkens H
Dtsch Med Wochenschr; 2006 Dec; 131(49 Suppl 9):S328-9. PubMed ID: 17139599
[TBL] [Abstract][Full Text] [Related]
62. Relation of bosentan, iloprost, and sildenafil with growth factor levels in monocrotaline-induced pulmonary hypertension.
Yigitaslan S; Sirmagul B
Clin Exp Hypertens; 2012; 34(3):222-9. PubMed ID: 22468718
[TBL] [Abstract][Full Text] [Related]
63. Long survival of congenital alveolar capillary dysplasia patient with NO inhalation and epoprostenol: effect of sildenafil, beraprost and bosentan.
Kodama Y; Tao K; Ishida F; Kawakami T; Tsuchiya K; Ishida K; Takemura T; Nakazawa A; Matsuoka K; Yoda H
Pediatr Int; 2012 Dec; 54(6):923-6. PubMed ID: 23279022
[TBL] [Abstract][Full Text] [Related]
64. Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension.
Goland S; Tsai F; Habib M; Janmohamed M; Goodwin TM; Elkayam U
Cardiology; 2010; 115(3):205-8. PubMed ID: 20173324
[TBL] [Abstract][Full Text] [Related]
65. Effects of epoprostenol and sildenafil on right ventricular function in hypoxic volunteers: a tissue Doppler imaging study.
Pavelescu A; Naeije R
Eur J Appl Physiol; 2012 Apr; 112(4):1285-94. PubMed ID: 21785860
[TBL] [Abstract][Full Text] [Related]
66. Systematic review and meta-analysis of pulmonary hypertension specific therapy for exercise capacity in chronic obstructive pulmonary disease.
Park J; Song JH; Park DA; Lee JS; Lee SD; Oh YM
J Korean Med Sci; 2013 Aug; 28(8):1200-6. PubMed ID: 23960448
[TBL] [Abstract][Full Text] [Related]
67. HIV-associated pulmonary hypertension: diagnosis and treatment.
Burkart KM; Farber HW
Adv Cardiol; 2003; 40():197-207. PubMed ID: 14533555
[No Abstract] [Full Text] [Related]
68. Clinical characteristics and outcome of 13 dogs with pulmonary arterial hypertension (PH) treated with sildenafil.
Moreno HJ
J Vet Intern Med; 2007; 21(6):1165. PubMed ID: 18196719
[No Abstract] [Full Text] [Related]
69. Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease.
Kuroda T; Hirota H; Masaki M; Sugiyama S; Oshima Y; Terai K; Ito A; Yamauchi-Takihara K
Heart Lung Circ; 2006 Apr; 15(2):139-42. PubMed ID: 16574537
[TBL] [Abstract][Full Text] [Related]
70. Sildenafil therapy for pulmonary hypertension before and after pediatric congenital heart surgery.
Palma G; Giordano R; Russolillo V; Cioffi S; Palumbo S; Mucerino M; Poli V; Vosa C
Tex Heart Inst J; 2011; 38(3):238-42. PubMed ID: 21720460
[TBL] [Abstract][Full Text] [Related]
71. Sildenafil as a treatment for pulmonary hypertension.
Carroll WD; Dhillon R
Arch Dis Child; 2003 Sep; 88(9):827-8. PubMed ID: 12937112
[TBL] [Abstract][Full Text] [Related]
72. Sildenafil in idiopathic pulmonary fibrosis.
Maher TM
N Engl J Med; 2010 Nov; 363(22):2169; author reply 2170-1. PubMed ID: 21105804
[No Abstract] [Full Text] [Related]
73. Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: the Treprostinil Sodium Inhalation Used in the Management of Pulmonary Arterial Hypertension (TRIUMPH) study open-label extension.
Benza RL; Seeger W; McLaughlin VV; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubin LJ
J Heart Lung Transplant; 2011 Dec; 30(12):1327-33. PubMed ID: 22055098
[TBL] [Abstract][Full Text] [Related]
74. Acute and chronic effects of sildenafil in patients with pulmonary arterial hypertension.
Preston IR; Klinger JR; Houtches J; Nelson D; Farber HW; Hill NS
Respir Med; 2005 Dec; 99(12):1501-10. PubMed ID: 15890512
[TBL] [Abstract][Full Text] [Related]
75. [Endothelin receptor antagonists in the new European guidelines on pulmonary hypertension].
Montani D; Humbert M
Rev Mal Respir; 2010 Feb; 27(2):103-5. PubMed ID: 20206056
[No Abstract] [Full Text] [Related]
76. Safety and efficacy of transition from subcutaneous treprostinil to oral sildenafil in patients with pulmonary arterial hypertension.
Keogh AM; Jabbour A; Weintraub R; Brown K; Hayward CS; Macdonald PS
J Heart Lung Transplant; 2007 Nov; 26(11):1079-83. PubMed ID: 18022071
[TBL] [Abstract][Full Text] [Related]
77. [Pulmonary arterial hypertension and systemic sclerosis].
Launay D; Humbert M; Hachulla E
Presse Med; 2006 Dec; 35(12 Pt 2):1929-37. PubMed ID: 17159719
[TBL] [Abstract][Full Text] [Related]
78. Treatment of pulmonary arterial hypertension.
Ricachinevsky CP; Amantéa SL
J Pediatr (Rio J); 2006 Nov; 82(5 Suppl):S153-65. PubMed ID: 17136291
[TBL] [Abstract][Full Text] [Related]
79. Sildenafil for pulmonary hypertension in ARDS: a new pleasant effect?
Blanch L; Albaiceta GM
Intensive Care Med; 2010 May; 36(5):729-31. PubMed ID: 20130829
[No Abstract] [Full Text] [Related]
80. Sildenafil in the treatment of pulmonary hypertension.
Barnett CF; Machado RF
Vasc Health Risk Manag; 2006; 2(4):411-22. PubMed ID: 17323595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
